Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha M Maher

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Inflammatory bowel disease: review and future viewMaha M Maher
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 27, 2010
Study of respiratory disorders in endoscopically negative and positive gastroesophageal reflux diseaseMaha M Maher, Amr A Darwish
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|July 2, 2009
Assessment of thrombophilic abnormalities during the active state of inflammatory bowel diseaseMaha M Maher, Somaya H Soloma
Gastroenterology Research|December 20, 2016
Study of Chronic Hepatopathy in Patients With Sickle Cell DiseaseMaha M Maher, Amany H Mansour
Cases Journal|December 3, 2008
Black esophagus: a case reportMaha M Maher, Mahmoud I Nassar
Digestive Diseases and Sciences|December 19, 2008
Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel diseaseMaha M Maher, Mahmoud I Nassar
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Oxidative stress and inflammatory bowel diseaseHazem A Almenier, Hazem H Al Menshawy, Maha M Maher, et al.
International Immunopharmacology|June 25, 2024
Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded studySahar M El-Haggar, Sahar K Hegazy, Maha M Maher, et al.
Inflammopharmacology|August 27, 2024
Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded studyMostafa M Bahaa, Sahar K Hegazy, Maha M Maher, et al.
Journal of Clinical Medicine|May 14, 2025
Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled StudyHayam Ali AlRasheed, Sahar M El-Haggar, Sahar K Hegazy, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Inflammatory bowel disease: review and future viewMaha M Maher
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 27, 2010
Study of respiratory disorders in endoscopically negative and positive gastroesophageal reflux diseaseMaha M Maher, Amr A Darwish
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|July 2, 2009
Assessment of thrombophilic abnormalities during the active state of inflammatory bowel diseaseMaha M Maher, Somaya H Soloma
Gastroenterology Research|December 20, 2016
Study of Chronic Hepatopathy in Patients With Sickle Cell DiseaseMaha M Maher, Amany H Mansour
Cases Journal|December 3, 2008
Black esophagus: a case reportMaha M Maher, Mahmoud I Nassar
Digestive Diseases and Sciences|December 19, 2008
Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel diseaseMaha M Maher, Mahmoud I Nassar
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Oxidative stress and inflammatory bowel diseaseHazem A Almenier, Hazem H Al Menshawy, Maha M Maher, et al.
International Immunopharmacology|June 25, 2024
Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded studySahar M El-Haggar, Sahar K Hegazy, Maha M Maher, et al.
Inflammopharmacology|August 27, 2024
Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded studyMostafa M Bahaa, Sahar K Hegazy, Maha M Maher, et al.
Journal of Clinical Medicine|May 14, 2025
Repurposing Atorvastatin, HMGCO-A Reductase Inhibitor, in Patients with Ulcerative Colitis: A Randomized Controlled StudyHayam Ali AlRasheed, Sahar M El-Haggar, Sahar K Hegazy, et al.
Pageof 2